Literature DB >> 2912182

Magnesium and reperfusion of ischemic rat heart as assessed by 31P-NMR.

P C Borchgrevink1, A S Bergan, O E Bakøy, P Jynge.   

Abstract

Isolated rat heart perfusion and high-resolution phosphate-31 nuclear magnetic resonance (31P-NMR) spectroscopy were used to elucidate the effects of Mg during reperfusion of the ischemic myocardium. After an ischemic period of 9 min, the hearts were reperfused with 0, 0.6, or 2.4 mM Mg during the entire 24-min reperfusion period or with 15 mM Mg during the first 12 min before returning to the physiological concentration of 0.6 mM during the last 12 min. Free intracellular Mg calculated by 31P-NMR rose during ischemia and fell gradually during reperfusion. The two groups reperfused with 15 mM Mg exhibited a significantly enhanced rate of recovery of adenosine triphosphate, creatine phosphate, intracellular pH, and coronary flow rate than the three other groups. Myocardial potassium was significantly higher, and inorganic phosphate was significantly lower at the end of the reperfusion period in these groups. The hearts reperfused with 0 mM Mg presented a significantly higher frequency of ventricular fibrillation (VF) than the other groups. It is concluded that reperfusion with high Mg improves the postischemic recovery of metabolism and function in the rat heart, whereas a Mg-free reperfusion solution increases the frequency of VF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912182     DOI: 10.1152/ajpheart.1989.256.1.H195

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  The effect of magnesium added to secondary cardioplegia on postischemic myocardial metabolism and contractile function--a 31P NMR spectroscopy and functional study in the isolated pig heart.

Authors:  G Tian; G P Biro; B Xiang; K W Butler; R Deslauriers
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

Review 2.  Regulation of L-type Ca2+ channels in the heart: overview of recent advances.

Authors:  Kaoru Yamaoka; Masaki Kameyama
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 3.  Possible pharmacological actions of magnesium in acute myocardial infarction.

Authors:  K L Woods
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 4.  [Mg(2+) transport in the heart. An overview].

Authors:  H Ebel
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 5.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

6.  Beneficial effect of magnesium on the isolated perfused rat heart during reperfusion after ischaemia: comparison between pre-ischaemic and post-ischaemic administration of magnesium.

Authors:  A Hara; H Matsumura; Y Abiko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

7.  Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes.

Authors:  E C Keung; Q Li
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 8.  Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence.

Authors:  Koon K Teo; Salim Yusuf
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

9.  Reversibility of mild to moderate ischemic injuries in the isolated rat heart. A characterization by 31P-NMR and by physiological and ultrastructural indices.

Authors:  G Greve; O E Bakøy; T Holten; P Jynge; T Saetersdal
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

10.  Effect of magnesium administered during postischemic reperfusion on myocardial oxidative metabolism in isolated rat hearts.

Authors:  C Tamm; I Papageorgiou; I Tardy; B Mermillod; W Rutishauser; R Lerch
Journal:  Basic Res Cardiol       Date:  1994 Jul-Aug       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.